CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-17 | Casdin Eli Director | Purchase | +2,492,042 | $2.60 | $6.5M | 6,078,860 |
| 2022-11-17 | Casdin Eli Director | Purchase · Warrant | +1,354,111 | $2.60 | $3.5M | 1,354,111 |
| 2022-09-08 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to buy) | +20,000 | 20,000 | ||
| 2022-06-10 | Walsh Jeffrey T. Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | Stehman-Breen Catherine Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | Srivastava Deepak Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | Lee June Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | GOEDDEL DAVID V Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | CHEN JIN-LONG Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | Casdin Eli Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-06-10 | Williams R Sanders Director | Grant or award · Stock Option (Right to buy) | +39,727 | 39,727 | ||
| 2022-04-26 | Hoey Timothy Chief Scientific Officer | Sale | −1,353 | $10.13 | $14K | 198,646 |
| 2022-02-15 | Ali Faraz Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +401,390 | 401,390 | ||
| 2022-02-15 | PATTERSON LEONE D Chief Fin. and Bus. Officer | Grant or award · Stock Option (Right to buy) | +66,000 | 66,000 | ||
| 2022-02-15 | Tingley Whittemore Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +141,000 | 141,000 | ||
| 2022-02-15 | Hoey Timothy Chief Scientific Officer | Grant or award · Stock Option (Right to buy) | +168,000 | 168,000 | ||
| 2021-12-22 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to Buy) | +19,495 | 19,495 | ||
| 2021-11-19 | Lee June Director | Grant or award · Stock Option (Right to Buy) | +18,937 | 18,937 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion | +4,389,282 | 4,414,720 | ||
| 2021-08-03 | COLUMN GROUP III GP, LP 10% owner | Conversion | +4,956,842 | 4,985,570 |
Page 10 of 12 · 228 trades